Latest filing published 02 Dec 2020 for Lixte Biotechnology Holdings, INC., €84k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
John S. Kovach: trading record in brief
This profile gathers the share dealings of John S. Kovach in Lixte Biotechnology Holdings, Inc. The record holds 3 filings, for trades running from 17 March 2015 to 30 November 2020.
No open-market sale appears; the market trades are 1 purchase worth €84k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2020, the count stands at 1 purchase and no sales.
On 2 December 2020 came the latest disclosure, an open-market purchase for €84k in Lixte Biotechnology Holdings, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John S. Kovach
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 21,100 shares@ US$4.75100.0% of flowCommon StockSEC:0001493152-20-022851:0Canonical exit: 28 Feb 2021 (T+90)
- 8,000,000 shares0Common stockSEC:0001493152-15-003388:0
- 92,717 shares@ US$1.00Common stockSEC:0001493152-15-000899:0
3 of 3 declarations
